Project Details
Description
This proposal outlines in vitro experiments designed to demonstrate efficacy of antisense oligonucleotides (ASO) to target KCNQ2-p.H228R in human induced pluripotent stem cell (hiPSC)-derived cortical excitatory neurons using a combination of molecular biological and electrophysiological approaches.
Status | Finished |
---|---|
Effective start/end date | 8/1/19 → 3/31/20 |
Funding
- Lydian Accelerator (Agmt 6/22/20)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.